
Experic is a contract development and manufacturing organization (CDMO) and clinical trial supply services company dedicated to revolutionizing pharmaceutical development, manufacturing, and clinical trial supply. Established in 2018, Experic offers a comprehensive suite of services, including process development, analytical and formulation development, clinical and commercial manufacturing, and clinical packaging and logistics. Specializing in challenging powders and inhalation products, our expertise encompasses tablets, pellets, capsules, and low-dose dry powder inhalation therapies.
Operating from our state-of-the-art, Class A cGMP facility in Cranbury, New Jersey, we manage the global delivery of high-quality products, even for expedited projects. Our team of industry leaders brings decades of experience in pharmaceutical product development and clinical trial supplies, ensuring strategic vision and execution for every project.
At Experic, we are committed to delivering innovative, client-focused services that accelerate the development and commercialization of life-changing therapies. Our flexible, customer-oriented approach addresses the growing needs of the biopharmaceutical industry, making us a trusted partner in bringing innovative products to market.
Experic
2 Clarke Drive
Cranbury, NJ 08512
USA

Customized and Scalable Dry Powder Inhalation (DPI) Product Development Services
With an experienced team, Experic offers state-of-the-art dry powder inhalation (DPI) capabilities and comprehensive services from DPI development and GMP manufacturing to packaging and distribution. More Info

Solve Development Scale Powder Challenges with Spray Drying Technology
In DPI formulations, particle engineering is a necessity for achieving both the product TPP and delivery to the lungs. Experic spray drying can help control particle size and morphology and enhance bioavailability. More Info

Analytical Services that Provide Powerful Support at Every Phase
Experic’s analytical services support formulation and process development, release testing of raw materials, API, and finished products, method development & validation, analysis of in-process samples, stability studies, and more. More Info

Inhaled Biologics: Formulation, Analysis and Regulation
As inhalation developers and manufacturers, how do we support the complexities of new biologics products? In this white paper, Justin Lacombe, Ph.D., Chief Scientific Officer, Experic, explores how we need to change our approach for biologics. More Info



